Search Results - C. Baldus

  • Showing 1 - 6 results of 6
Refine Results
  1. 1

    P490: SNORNA-DERIVED RNAS (SDRNAS) ARE IMPORTANT DRIVERS OF LEUKEMOGENESIS AND LEUKEMIC MAINTENANCE IN AML by R. Zinz, C. Rohde, D. Heid, M. Bruckmann, M. Bornhäuser, C. Röllig, U. Platzbecker, C. Baldus, H. Serve, F. Zhou, C. Pabst, C. Müller-Tidow, M. F. Blank

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  2. 2

    P1448: LONG-TERM SURVIVORS AFTER FAILURE OF CAR-T CELL THERAPY FOR R/R LARGE B-CELL LYMPHOMA (LBCL): A GLA/DRST STUDY by P. Derigs, W. Bethge, U. Holtick, B. von Tresckow, F. Ayuk, O. Penack, V. Vucinic, M. von Bonin, C. Baldus, D. Mougiakakos, G. Wulf, U. Schnetzke, M. Stelljes, S. Thomas, R. Schroers, N. Kroeger, P. Dreger

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  3. 3

    S106: UBTF-ATXN7L3 GENE FUSION DUE TO 17Q21.31 DELETION DEFINES NOVEL HIGH-RISK ALL SUBTYPE AMENABLE TO MRD-BASED TREATMENT INTENSIFICATION by L. Bastian, A. Hartmann, T. Beder, S. Hänzelmann, J. Kässens, M. Bultmann, M. P. Höppner, S. Franzenburg, M. Wittig, A. Franke, I. Nagel, M. Spielmann, N. Reimer, H. Busch, S. Schwartz, B. Steffen, A. Viardot, K. Döhner, M. Kondakci, G. Wulf, K. Wendelin, A. Renzelmann, A. Kiani, H. Trautmann, M. Neumann, N. Gökbuget, M. Brüggemann, C. Baldus

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  4. 4

    P404: PROGNOSTIC IMPACT OF CEBPA-MUTATIONAL SUBGROUPS IN ADULT AML – RESULTS OF A LARGE METAANALYSIS IN MORE THAN 1000 CEBPA-MUTANT PATIENTS by J.-A. Georgi, S. Stasik, M. Kramer, C. Röllig, T. Haferlach, P. Valk, D. Linch, T. Herold, N. Duployez, F. Taube, U. Platzbecker, H. Serve, C. Baldus, C. Müller-Tidow, C. Haferlach, M. Meggendorfer, S. Koch, E. L. Boertjes, R. K. Hills, A. Burnett, G. Ehninger, K. Metzeler, M. Rothenberg-Thurley, A. Dufour, H. Dombret, C. Pautas, L. Fenwarth, M. Bornhäuser, R. Gale, C. Thiede

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  5. 5

    P454: VENETOCLAX AND GILTERITINIB SYNERGIZE IN FLT3 WILDTYPE ACUTE MYELOID LEUKEMIA BY SUPPRESSION OF MCL-1 VIA COMBINED AXL AND FLT3 TARGETING by C. Schmidt, M. Janssen, P.-M. Bruch, M. F. Blank, C. Rohde, A. Waclawiczek, S. Renders, D. Heid, S. Göllner, L. Vierbaum, K. Weidenauer, S. Herbst, M. Knoll, C. Kolb, B. Besenbeck, M. Fabre, M. Gu, R. Schlenk, F. Stölzel, M. Bornhäuser, C. Röllig, U. Platzbecker, C. Baldus, H. Serve, T. Sauer, S. Raffel, C. Pabst, G. Vassiliou, B. Vick, I. Jeremias, A. Trumpp, J. Krijgsveld, C. Müller-Tidow, S. Dietrich

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  6. 6

    P545: CHARACTERISTICS AND OUTCOME OF PATIENTS WITH ACUTE MYELOID LEUKEMIA AND TRISOMY 19 by S. Kayser, D. Martínez-Cuadrón, R. Rodriguez-Veiga, M. Hänel, M. Tormo, K. Schäfer-Eckart, C. Botella, F. Stölzel, T. Bernal del Castillo, U. Keller, C. Rodriguez-Medina, G. Held, M.-L. Amigo, C. Schliemann, M. Colorado, M. Kaufmann, M. Barrios Garcia, S. W. Krause, M. Görner, E. Jost, B. Steffen, A. D. Ho, C. Baldus, H. Serve, U. Platzbecker, C. Müller-Tidow, C. Thiede, M. Bornhäuser, P. Montesinos, C. Röllig, R. F. Schlenk

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


Search Tools: